Clinical Trial Update: A Phase I/II Study of ABI-007 (Abraxane®, Nab®-Paclitaxel)and Vinorelbine in Patients With Stage IV (Metastatic) Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II study of Abraxane (nab-paclitaxel) with vinorelbine in metastatic breast cancer was terminated with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Nab-paclitaxel (paclitaxel protein-bound)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Celgene | Conditions: Stage IV (Metastatic) Breast Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2013-10-24